Skip to main content
Clinical Trials/IRCT20180513039646N1
IRCT20180513039646N1
Completed
Phase 3

The effect of the family-centered educational program on medication management and quality of life in elderly patients with ischemic heart disease

Tehran University of Medical Sciences0 sites84 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Ischemic Heart Disease.
Sponsor
Tehran University of Medical Sciences
Enrollment
84
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Reading and writing literacy (for patient or family member)
  • Age between 60 and 75 years
  • The absence of diagnosed psychological illness
  • Ischemic Heart Disease Detected by Heart Disease
  • At least 6 months have passed since the diagnosis of the disease and has a sustained pain and hemodynamic status
  • A positive response to two or more questions is the HbL Drug Dangers Questionnaire that is used to assess the problems associated with drug use in the elderly.
  • Residence of an active member of the family at or near the patient's place of residence

Exclusion Criteria

  • Entry into the acute phase of the disease
  • The company participated simultaneously in other similar specialized studies
  • Having even a session absent in the classroom for a patient or family member
  • Unwillingness (patient and active member of the family) to continue participating in the study or death of a sick person or an active member of the family
  • Do not answer phone at least for two times

Outcomes

Primary Outcomes

Not specified

Similar Trials